Similar articles for PMID: 15951551

Year	Number of Results
1992	1
1994	1
1995	2
1996	1
1997	1
1998	4
1999	1
2000	3
2001	4
2002	6
2003	2
2004	3
2005	7
2006	3
2007	14
2008	3
2009	1
2010	3
2011	3
2012	4
2013	2
2014	4
2015	5
2016	4
2017	1
2018	3
2019	2
2020	1
2022	2
2024	0

1

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D.

Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, Häussinger D. Erhardt A, et al. Gut. 2005 Jul;54(7):1009-13. doi: 10.1136/gut.2004.060327. Gut. 2005. PMID: 15951551 Free PMC article.

2

Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.

Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, Janssen HL. Buster EH, et al. Gastroenterology. 2009 Dec;137(6):2002-9. doi: 10.1053/j.gastro.2009.08.061. Epub 2009 Sep 6. Gastroenterology. 2009. PMID: 19737568

3

Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.

Chen CH, Lee CM, Hung CH, Wang JH, Hu TH, Changchien CS, Lu SN. Chen CH, et al. J Gastroenterol Hepatol. 2011 Mar;26(3):461-8. doi: 10.1111/j.1440-1746.2010.06429.x. J Gastroenterol Hepatol. 2011. PMID: 21332543

4

[Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].

Lu HY, Zhuang LW, Yu YY, Si CW, Li J. Lu HY, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Mar;16(3):198-202. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18364079 Clinical Trial. Chinese.

5

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.

Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T. Sakai T, et al. Int J Mol Med. 2002 Aug;10(2):201-4. Int J Mol Med. 2002. PMID: 12119559

6

Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.

Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Brunetto MR, Farci P, Popescu M, McCloud P; Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group. Bonino F, et al. Gut. 2007 May;56(5):699-705. doi: 10.1136/gut.2005.089722. Epub 2006 Nov 24. Gut. 2007. PMID: 17127704 Free PMC article. Clinical Trial.

7

Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.

Hou J, Schilling R, Janssen HL, Hansen BE, Heijtink R, Sablon E, Williams R, Lau GK, Schalm SW, Naoumov NV. Hou J, et al. J Med Virol. 2007 Aug;79(8):1055-63. doi: 10.1002/jmv.20935. J Med Virol. 2007. PMID: 17596838

8

[Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients].

Fan HB, Guo YB, Luo KX, Hou JL, Wang ZH, Zhang MX. Fan HB, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jul;13(7):488-90. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16042879 Chinese.

9

[HBV genotype and liver histology effect of peginterferon alpha treatment of HBeAg-position chronic hepatitis B].

Lu CT, Gao GS, Yan HD, Hu YR. Lu CT, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Jun;27(3):193-5. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013. PMID: 24319954 Chinese.

10

Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.

Kong LN, Qin B, Ma Q, Li L, Yao Y. Kong LN, et al. J Gastroenterol Hepatol. 2014;29(7):1387-95. doi: 10.1111/jgh.12559. J Gastroenterol Hepatol. 2014. PMID: 24548048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year